Treatment Outcomes of Sacral Giant Cell Tumor.
10.5292/jkbjts.2013.19.2.43
- Author:
Chang Bae KONG
1
;
Kwang Youl LEE
;
Won Seok SONG
;
Wan Hyeong CHO
;
Jae Soo KOH
;
Dae Geun JEON
;
Soo Yong LEE
Author Information
1. Department of Orthopedic Surgery, Korea Cancer Center Hospital, Seoul, Korea. wssongmd@gmail.com
- Publication Type:Original Article
- Keywords:
giant cell tumor;
sacrum;
treatment
- MeSH:
Curettage;
Female;
Follow-Up Studies;
Giant Cell Tumors*;
Giant Cells*;
Humans;
Male;
Retrospective Studies;
Sacrum
- From:The Journal of the Korean Bone and Joint Tumor Society
2013;19(2):43-49
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: We analyzed the treatment outcomes of patients with sacral giant cell tumor. MATERIALS AND METHODS: We retrospectively reviewed 7 patients with giant cell tumor of the sacrum who were treated at out institution between 1990 and 2012. RESULTS: There were 2 men and 5 women with mean age of 23.6 years. The average follow up was 52.3 months (range, 15-73 months). Six patients received surgical treatment. Intralesional curettage was performed for the 5 patients and marginal resection for another one patient. The remaining one patient was received radiation only. The patients who received radiation therapy and marginal excision had no residual or recurrent tumors. Of 5 patients with intra-lesional excision, one patient needs one more operation; two patients need two more operation for local control of the giant cell tumor. The remaining two patients failed to gain local control in spite of additional treatments. CONCLUSION: For the treatment of sacral giant cell tumor, intralesional resection can be one of the treatments option with minimal neurologic injury. Furthermore, radiation therapy can be recommended when complete excision or curettage is impractical.
